On 14 February, the European Parliament voted to establish a dedicated Public health sub-committee, that will focus on public health, pharmaceutical and cosmetic products, health aspects of bioterrorism, the European Medicines Agency and the European Centre for Disease Prevention and Control. The sub-committee will comprise… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of nine (9) new members at its quarterly Members Meeting on February 14th, 2023 following Board approval. The new members joining EUCOPE network are Admedicum, Ardena, Avanzanite Bioscience, Emergent Biosolutions, Evoke Incisive Health, Insmed, Lif… read more
Sounds of Science – Episode 12 The new EU HTA Procedure: Getting it right to improve patients’ access to innovative therapies With the entry into force of the EU HTA Regulation in January 2022, the European Commission and EUnetHTA21, a consortium of Member States HTA… read more
On 25 January 2023, EUCOPE joined an industry coalition calling for better alignment of the Data Act with the GDPR Draft opinion by LIBE Committee as it risks curbing the benefits for innovation and is at odds with the Data Act’s objective to empower users…. read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In January, we spoke with Jameel Nazir, Vice President Patient Access and Community Engagement at Sobi – Swedish Orphan… read more
As previously outlined in the EPSCO Council (Health) meeting on 9 December 2022 (Information Note), the European Commission adopted draft legislation on 6 January 2023 amending Regulations (EU) 2017/745 (Medical Devices Regulation – MDR) and (EU) 2017/746 (In Vitro Diagnostics Regulation – IVDR) as regards the transitional… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of three (3) new Associate members on 1 January 2023. The new members joining EUCOPE network are: APCO Worldwide, RareLab and SKC. During the announcement, EUCOPE’s Secretary General Alexander Natz said, “The new year means… read more
Sounds of Science – Episode 11 2022 Year in Review: Our Policy team’s perspectives on the past year in EU Health and a look ahead to 2023 Throughout 2022, there have been successes, challenges, delays and change within the European pharmaceutical industry and we expect… read more
Sounds of Science Podcast – Episode 10 Launch Conditionality: The impact on small and mid-sized companies Within the European Commission’s ongoing review of the General Pharmaceutical Legislation and Orphan Medicinal Products (OMP) Regulation, there are several potentially controversial policy options that aim to enhance access… read more
A new initiative to boost research and development into rare and paediatric diseases will launch today [Thursday 8 December] at the European Health Summit. The ‘Rare Disease Moonshot’ is a commitment and collaboration between seven organisations to break down the barriers to finding new treatments and cures… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View